<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report 67 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> erythroid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e>) based on the World Health Organization (WHO) 2008 classification </plain></SENT>
<SENT sid="1" pm="."><plain>Reviewing the clinicopathologic features, cytogenetics and outcomes, the characteristics of <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> resembled <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with poor performance status, advanced <z:hpo ids='HP_0001903'>anemia</z:hpo> and poor-risk cytogenetics had significantly inferior outcomes </plain></SENT>
<SENT sid="3" pm="."><plain>The International Prognostic Scoring System (IPSS) for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is useful to differentiate the prognosis of <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> </plain></SENT>
</text></document>